Highlights Paxman AB

Equities

PAX

SE0009806284

Delayed Nasdaq Stockholm Other stock markets 11:29:31 2024-04-29 am EDT			5-day change	1st Jan Change
37.5 ^SEK	-0.79%		+6.84%	+1.90%

Jan. 15	Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 14	CI
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17	CI
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	23-10-03	CI
Paxman AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24	CI
Paxman AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-24	CI
Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-24	CI
Paxman Scalp Cooling System Receives EU MDR Certification	23-01-26	CI
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-18	CI
Paxman AB Announces Its Selection by the SWOG Cancer Research Network for the Paxman Limb Cryocompression System to Be Used in A Prospectively Designed Study Looking At Prevention of Chemotherapy-Induced Peripheral Neuropathy	22-11-15	CI
Paxman AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-24	CI
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-25	CI
Paxman Launches Enhanced Provider and Patient Assistance Services, as Well as Offering A New Business Model to Health Systems	22-05-09	CI
Paxman AB Signs Letter of Interest with Guangzhou Concord Medical Sci-Tech Innovation Center Co. Ltd. to Enter into Distribution and Marketing Agreement	22-04-12	CI
Paxman AB Signs New Distribution Agreement with Partner in Serbia	22-03-30	CI
Paxman AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-25	CI
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-19	CI
Paxman AB Announces Nelson Arcos S.A. as Their Global Distribution Partner for Paxman Equipment in Uruguay	21-11-11	CI
Paxman opens CIPN Clinical Trial with National University Hospital, Singapore	21-11-04	CI
Paxman AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Paxman AB

Equities

PAX

SE0009806284

Highlights

Filters